Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk?
Crossref DOI link: https://doi.org/10.1245/s10434-016-5333-x
Published Online: 2016-07-08
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kitano, Mio
Davidson, Gail W.
Shirley, Lawrence A.
Schmidt, Carl R.
Guy, Gregory E.
Khabiri, Hooman
Dowell, Joshua D.
Shah, Manisha H.
Bloomston, Mark
License valid from 2016-07-08